Gilead Sciences / CAPRISA / HIV Prevention / FHI 360 / Setshaba Research Center Technology Innovation Agency CAPRISA / /
Country
South Africa / Kenya / Malawi / Tanzania / Botswana / /
Event
Business Partnership / /
Facility
University of KwaZulu-Natal / Tropical Medicine JOSHA Research Kilimanjaro Christian Medical Centre / South Africa Columbia University CONRAD Gilead Sciences Gladstone Institutes IMPACT Research and Development Organization Institute / University of San Francisco / Laboratory Proficiency Trials Innovative Techniques / University of North Carolina / Chapel Hill / /
IndustryTerm
field program management / rural site / prevention of HIV / HIV Prevention / urban site / project management / microbicide services / HIV treatment / reproductive health technologies / study site / active product / data management / study product / health systems / gender analysis tool / on delivering microbicide services / /
MedicalCondition
HIV / genital herpes / herpes / HIV infections / infections / HIV infection / genital herpes infection / AIDS / infection / half a million new HIV infections / /
MedicalTreatment
contraception / /
NaturalFeature
Chapel Hill / /
Organization
University of North Carolina / and Development Organization Institute / University of KwaZulu-Natal / United States Agency for International Development / Research in South Africa / United Nations / U.S. Food and Drug Administration / Centre for the AIDS Programme of Research in South Africa / Centre for the AIDS Programme of Research in South Africa Columbia University / Tropical Medicine JOSHA Research Kilimanjaro Christian Medical Centre London School of Hygiene / University of San Francisco / /
Person
Jessica Scranton / Natalie Eley / James Kilonzo / Sarah Mullins / Leigh Wynne / Michele Lanham / Ian Taylor / Natasha Mack / Kim Best / /
END-OF-PROJECT REPORT Preventive Technologies Agreement (PTA) Advancing the Science of HIV Prevention